These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 29370834)

  • 1. Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.
    Chalmers SA; Wen J; Doerner J; Stock A; Cuda CM; Makinde HM; Perlman H; Bosanac T; Webb D; Nabozny G; Fine JS; Klein E; Ramanujam M; Putterman C
    Arthritis Res Ther; 2018 Jan; 20(1):10. PubMed ID: 29370834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
    Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HM71224, a selective Bruton's tyrosine kinase inhibitor, attenuates the development of murine lupus.
    Kim YY; Park KT; Jang SY; Lee KH; Byun JY; Suh KH; Lee YM; Kim YH; Hwang KW
    Arthritis Res Ther; 2017 Sep; 19(1):211. PubMed ID: 28950886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFN
    Katewa A; Wang Y; Hackney JA; Huang T; Suto E; Ramamoorthi N; Austin CD; Bremer M; Chen JZ; Crawford JJ; Currie KS; Blomgren P; DeVoss J; DiPaolo JA; Hau J; Johnson A; Lesch J; DeForge LE; Lin Z; Liimatta M; Lubach JW; McVay S; Modrusan Z; Nguyen A; Poon C; Wang J; Liu L; Lee WP; Wong H; Young WB; Townsend MJ; Reif K
    JCI Insight; 2017 Apr; 2(7):e90111. PubMed ID: 28405610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
    Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
    J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
    Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
    Front Immunol; 2018; 9():2189. PubMed ID: 30319641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.
    Haselmayer P; Camps M; Liu-Bujalski L; Nguyen N; Morandi F; Head J; O'Mahony A; Zimmerli SC; Bruns L; Bender AT; Schroeder P; Grenningloh R
    J Immunol; 2019 May; 202(10):2888-2906. PubMed ID: 30988116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
    Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of Bruton's tyrosine kinase in peripheral blood is associated with lupus nephritis.
    Kong W; Deng W; Sun Y; Huang S; Zhang Z; Shi B; Chen W; Tang X; Yao G; Feng X; Sun L
    Clin Rheumatol; 2018 Jan; 37(1):43-49. PubMed ID: 28612243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
    Stock AD; Wen J; Doerner J; Herlitz LC; Gulinello M; Putterman C
    J Neuroinflammation; 2015 Nov; 12():205. PubMed ID: 26546449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Bruton's Tyrosine Kinase in Immune Cell Signaling and Systemic Autoimmunity.
    Rip J; Van Der Ploeg EK; Hendriks RW; Corneth OBJ
    Crit Rev Immunol; 2018; 38(1):17-62. PubMed ID: 29717662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus.
    Shi D; Tian T; Yao S; Cao K; Zhu X; Zhang M; Wen S; Li L; Shi M; Zhou H
    Brain Behav Immun; 2018 May; 70():293-304. PubMed ID: 29548997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Btk inhibition treats TLR7/IFN driven murine lupus.
    Bender AT; Pereira A; Fu K; Samy E; Wu Y; Liu-Bujalski L; Caldwell R; Chen YY; Tian H; Morandi F; Head J; Koehler U; Genest M; Okitsu SL; Xu D; Grenningloh R
    Clin Immunol; 2016 Mar; 164():65-77. PubMed ID: 26821304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BTK inhibition modulates multiple immune cell populations involved in the pathogenesis of immune mediated nephritis.
    Chalmers SA; Garcia SJ; Webb D; Herlitz L; Fine J; Klein E; Ramanujam M; Putterman C
    Clin Immunol; 2021 Feb; 223():108640. PubMed ID: 33296718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
    Mina-Osorio P; LaStant J; Keirstead N; Whittard T; Ayala J; Stefanova S; Garrido R; Dimaano N; Hilton H; Giron M; Lau KY; Hang J; Postelnek J; Kim Y; Min S; Patel A; Woods J; Ramanujam M; DeMartino J; Narula S; Xu D
    Arthritis Rheum; 2013 Sep; 65(9):2380-91. PubMed ID: 23754328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice.
    Deng GM; Liu L; Bahjat FR; Pine PR; Tsokos GC
    Arthritis Rheum; 2010 Jul; 62(7):2086-92. PubMed ID: 20222110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus.
    Sheng L; Cao X; Chi S; Wu J; Xing H; Liu H; Yang Z
    Int J Mol Med; 2020 Oct; 46(4):1409-1422. PubMed ID: 32945349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruton's Tyrosine Kinase, a Component of B Cell Signaling Pathways, Has Multiple Roles in the Pathogenesis of Lupus.
    Satterthwaite AB
    Front Immunol; 2017; 8():1986. PubMed ID: 29403475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.
    Wen J; Doerner J; Weidenheim K; Xia Y; Stock A; Michaelson JS; Baruch K; Deczkowska A; Gulinello M; Schwartz M; Burkly LC; Putterman C
    J Autoimmun; 2015 Jun; 60():40-50. PubMed ID: 25911200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.